IGF1 and obesity disorder: Hyperinsulinemia and insulin resistance, common in individuals with obesity, further elevate cancer risk by increasing circulating insulin-like growth factor 1 (IGF-1), which has mitogenic and anti-apoptotic properties (32–34).